These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8973849)

  • 21. Re: Vinorelbine-induced pancreatitis: a case report.
    Raderer M; Kornek G; Scheithauer W
    J Natl Cancer Inst; 1998 Feb; 90(4):329. PubMed ID: 9486821
    [No Abstract]   [Full Text] [Related]  

  • 22. Navelbine promising as a radiosensitizer in non-small-cell lung cancer.
    Oncology (Williston Park); 1995 Aug; 9(8):783. PubMed ID: 7577378
    [No Abstract]   [Full Text] [Related]  

  • 23. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1994 Jun; 271(23):1818. PubMed ID: 7910857
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of vinorelbine for breast cancer.
    Smith GA
    Oncology (Williston Park); 1995 Aug; 9(8):767-73; discussion 774, 776, 779. PubMed ID: 7577376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update: vinorelbine (navelbine) in non-small cell lung cancer.
    Crawford J
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New directions for chemotherapy in non-small-cell lung cancer.
    Green MR
    Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
    Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
    Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New directions in the treatment of non-small cell lung cancer: an overview.
    Edelman MJ
    Oncologist; 2001; 6 Suppl 1():1-3. PubMed ID: 11181996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Navelbine (Vinorelbin)--current trends and results. Satellite Symposium on occasion of the 22nd German Cancer Congress. Berlin, 20 February 1996].
    Pneumologie; 1996 Apr; 50(4 Suppl):1-4. PubMed ID: 9022415
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of non-small-cell lung cancer in an older adult with complications responding to vinorelbine single agent].
    Nagasawa M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1673-4. PubMed ID: 21996964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Navelbine (vinorelbine): new antitumoral agent. Biarritz, November 2-3, 1989].
    Lhommé C
    Rev Prat; 1990 Sep; 40(19):1780-1. PubMed ID: 2171131
    [No Abstract]   [Full Text] [Related]  

  • 32. Vinorelbine approved for advanced non-small-cell lung cancer.
    Am J Health Syst Pharm; 1995 Apr; 52(7):678. PubMed ID: 7627734
    [No Abstract]   [Full Text] [Related]  

  • 33. The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.
    Gridelli C
    Oncologist; 2001; 6 Suppl 1():4-7. PubMed ID: 11181997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients.
    Veronesi A; Crivellari D; Magri MD; Cartei G; Mansutti M; Foladore S; Monfardini S
    Eur J Cancer; 1996 Sep; 32A(10):1809-11. PubMed ID: 8983294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinorelbine in pregnancy.
    Cuvier C; Espie M; Extra JM; Marty M
    Eur J Cancer; 1997 Jan; 33(1):168-9. PubMed ID: 9071921
    [No Abstract]   [Full Text] [Related]  

  • 36. Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
    Le Chevalier T; Brisgand D; Soria JC; Douillard JY; Pujol JL; Ruffie P; Aberola V; Cigolari S
    Oncologist; 2001; 6 Suppl 1():8-11. PubMed ID: 11181998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
    J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinorelbine-associated myelopathy in a patient who previously received paclitaxel: a case report.
    Han JY; Choi BG; Song DH; Ahn JG; Yoon JS; Lee KS
    Med Oncol; 2001; 18(1):95-7. PubMed ID: 11778975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine tartrate.
    Chan BM; Ignoffo RJ
    Cancer Pract; 1995; 3(5):320-3. PubMed ID: 7663552
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD; Logan DM; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.